Affordable coronavirus vaccine could be supplied by my company: Dyadic International CEO
Dyadic International CEO Mark Emalfarb discusses how his company could expedite the production of an affordable coronavirus vaccine.
Coronavirus panic has ravaged global markets driving stocks to their worst weekly loss since the 2008 financial crisis. Fears continue to mount despite re-assurances from everyone from President Trump to Fed Chair Jay Powell. Now, the CEO of the biotech firm Dyadic International is joining the chorus, but his reassurance comes in the form of a potential vaccine.
Continue Reading Below
In an exclusive interview, Dyadic CEO Mark Emalfarb told FOX Business’ Trish Regan Friday that his company has the technology that will allow them to mass-produce a vaccine should one get approved in the next several months. "We developed the technology platform that we've been developing for years over two and half decades to make proteins at large scale, at very low cost," he said.
US REPORTS FIRST DRUG SHORTAGE TIED TO CORONAVIRUS, WARNS IT COULD GET WORSE